IC
Ikarian Capital, LLC disclosed a 9.9% stake in AEON
Ikarian Capital, LLC reported owning 9.9% of AEON Biopharma, Inc. (AEON) (7,362,438 shares) in a Schedule 13G filed Nov 17, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.